A new vaccine developed by Moderna offers 95 percent effectiveness against COVID-19, early data from the US company Moderna shows. The results are consistent with those delivered by Pfizer’s vaccine last week. Neal Browning, the second volunteer to receive Moderna’s COVID-19 vaccine during the phase one trial in March, has spoken out about the side effects.